Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can special lenses slow eye growth in nearsighted kids?

NCT ID NCT07780851

Knowledge-focused Sponsor: Essilor International Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 24, 2026 · Last updated Aug 25, 2026 · Updated 1 time

Summary

This study looks at how children with myopia (nearsightedness) move their eyes and heads while doing close-up tasks with different types of glasses. It compares standard single-vision lenses with special myopia control lenses to see if these lenses change viewing behavior and whether wearing them for one month affects eye length. The findings could help improve lens designs to better manage myopia in children.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Myopia control spectacle lenses (Stellest) compared with standard single vision lenses
What this could lead to
If successful, this could help refine myopia control lens designs to better slow eye growth in children.
What could go wrong
This is a small, short-term study, so results may not apply broadly or predict long-term effects on myopia progression.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

20 people

The number who actually took part.

Started

Apr 2025

Finished

Mar 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

8 to 15 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Between 8 and 15 years of age * No amblyopia * No tropia * No known/reported ocular pathology * Myopes with spherical equivalent refraction of -0.50 D to -6.00 D * Astigmatism of less than -4.00 D * Anisometropia of less than -1.50D * Best corrected monocular VA better than 0.10 logMAR in both eyes * Able to follow the protocol * Wearing habitual correction Exclusion Criteria: * Currently or previously on any myopia control interventions (I.e., Myopia control spectacle lenses, myopia control contact lenses, orthokeratology lenses or atropine, etc.) * Myopes who do not have a pair of habitual glasses

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Myopia are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

myopia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Myopia

Contacts and locations

Locations

  • Singapore Polytechnic Optometry Centre (SPOC)

    Singapore, Singapore, 139651, Singapore

More trials for these conditions

Other studies related to the condition(s) this trial covers.